l8171518k.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 8-K
 

 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 14, 2015
 

 
Skyline Medical Inc.
(Exact name of Registrant as Specified in its Charter)
 
Delaware
000-54361
33-1007393
     
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
     
2915 Commers Drive, Suite 900
Eagan, Minnesota
 
55121
(Address of Principal Executive Offices)
(Zip Code)

Registrant's telephone number, including area code: (651) 389-4800

Former Name or Former Address, if Changed Since Last Report: Not Applicable
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
                
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


 
 

 
 
Item 8.01               Other Events.
 
On August 14, 2015, the board of directors of Skyline Medical Inc. (the “Company”) appointed Frank Mancuso, Jr., a current director of the Company, to serve on its audit committee. The current members of the audit committee of the board of directors are Thomas J. McGoldrick, as the chairperson, Andrew P. Reding and Frank Mancuso, Jr.
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
 
SKYLINE MEDICAL INC.
     
     
     
 
By:
/s/ Josh Kornberg
     
   
Name: Josh Kornberg
Title: President and Chief Executive Officer

Date: August 17, 2015